Health of Pessary Versus Progesterone Supplement for Preventing Preterm Birth Children

Sponsor
Mỹ Đức Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04295187
Collaborator
(none)
529
1
9.1
57.9

Study Details

Study Description

Brief Summary

To give strong recommendations on the efficacy and safety of vaginal progesterone versus cervical cerclage, we conduct this study to investigate the physical and mental development of children from vaginal progesterone versus cervical cerclage. Based on our research (Dang et al., 2019), the twin pregnancies with cervical lengths less than 38mm were randomly assigned to receive vaginal progesterone or cervical cerclage, which leads to the similarity in characteristics of these two groups. Hence, the result of analyzing these offsprings would be preciously valuable.

Condition or Disease Intervention/Treatment Phase
  • Other: Developmental score according to The Ages & Stages Questionnaires®, Third Edition - ASQ®-3
  • Other: Physical development and General Health
  • Other: Developmental Red flags

Detailed Description

Preterm birth (PB) is the leading cause of neonatal morbidity and mortality. Twin pregnancies and short cervical length are two high-risk factors of PB. Generally, in singleton pregnancies with short cervical length below 25 mm, or with a history of preterm birth, preventive measures of PB are vaginal progesterone and cervical cerclage. The cervical pessary is also being investigated for effectiveness in PB prevention in different populations. However, the effective preventive methods for PB has not been identified up to now in twin pregnancies with short cervical length.

In our research, the results showed that the preterm birth rate before 34 weeks in the cervical pessary group was lower than the progesterone group (16% vs 22%, RR 0.73; 95% CI 0.46 - 1.18). The perinatal outcomes were also better in the cervical pessary group than in the progesterone group (19% vs 27%, RR 0.70; 95% CI 0.43 - 0.93). The cost of the cervical pessary method was also significantly lower than the vaginal progesterone method cost. Pessary insertion was also more convenient since it was only inserted once during pregnancy, compared to daily vaginal progesterone. Therefore, the cervical pessary may be an appropriate option for preventing preterm birth in twin pregnancies with a short cervix.

However, besides these short-term outcomes, we need to pay more attention to the longer-term issues of both mothers and infants. Some evidence up to now has demonstrated that both these two methods are safe with no impact on physical, mental, and motor development of children up to 3 years old and even in older children. However, such evidence is still rare. Also, there hasn't been any study evaluating the impact, if any, of these two PB preventive methods.

Study Design

Study Type:
Observational
Actual Enrollment :
529 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Physical, Mental and Motor Development of Children Born to Mothers Treated With Pessary or Progesterone Supplement for Preventing Preterm Birth
Actual Study Start Date :
Mar 6, 2020
Actual Primary Completion Date :
Jul 15, 2020
Actual Study Completion Date :
Dec 9, 2020

Arms and Interventions

Arm Intervention/Treatment
Cervical pessary

Cervical pessary (Arabin) will be inserted to participants at 16-22 weeks and removed at 37 weeks of pregnancy or in case of premature rupture of membranes, signs of preterm labour or patient severe discomfort.

Other: Developmental score according to The Ages & Stages Questionnaires®, Third Edition - ASQ®-3
Ages & Stages Questionnaires®, Third Edition (ASQ®-3) is a developmental screening tool designed for use by early educators and health care professionals. It relies on parents as experts, is easy-to-use, family-friendly and creates the snapshot needed to catch delays and celebrate milestones.

Other: Physical development and General Health
Physical development and General health examination

Other: Developmental Red flags
Developmental Red flags Questionnaires

Vaginal Progesterone

Vaginal progesterone (Cyclogest 200 mg) once a day will be used, from 16-22 to 37 weeks of pregnancy or in case of premature rupture of membranes, signs of preterm labour or patient severe discomfort.

Other: Developmental score according to The Ages & Stages Questionnaires®, Third Edition - ASQ®-3
Ages & Stages Questionnaires®, Third Edition (ASQ®-3) is a developmental screening tool designed for use by early educators and health care professionals. It relies on parents as experts, is easy-to-use, family-friendly and creates the snapshot needed to catch delays and celebrate milestones.

Other: Physical development and General Health
Physical development and General health examination

Other: Developmental Red flags
Developmental Red flags Questionnaires

Outcome Measures

Primary Outcome Measures

  1. The average total ASQ-3 score [Up to 66 months after birth]

    ASQ-3 (Ages and Stages Questionaires®) has 5 aspects: Communication, Gross motor, Fine motor, Problem solving and Personal-Social Each aspect has 6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0. ASQ-3 average = average score of 5 aspects.

Secondary Outcome Measures

  1. Score of Communication [Up to 66 months after birth]

    6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0. Total score will be used: minimum = 0 and maximum = 60. Each aspects in each stages has alternative threshold

  2. Score of Gross motor [Up to 66 months after birth]

    6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0. Total score will be used: minimum = 0 and maximum = 60. Each aspects in each stages has alternative threshold

  3. Score of Fine motor [Up to 66 months after birth]

    6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0. Total score will be used: minimum = 0 and maximum = 60. Each aspects in each stages has alternative threshold

  4. Score of Problem solving [Up to 66 months after birth]

    6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0. Total score will be used: minimum = 0 and maximum = 60. Each aspects in each stages has alternative threshold

  5. Score of Personal-Social [Up to 66 months after birth]

    6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0. Total score will be used: minimum = 0 and maximum = 60. Each aspects in each stages has alternative threshold

  6. The rate of children who have at least one red flag sign [From 2 to 5.5 years after birth]

    He or she has at least one red flag sign by age From 2 to < 3 year-old: Has very unclear speech Doesn't understand simple instruction • Doesn't speak in sentences Doesn't make eye contact Loses skills he/she once had From 3 to < 4 year-old: Can't jump in place Doesn't play pretend or make-believe • Speaks unclearly Can't retell a favorite story Doesn't use "me" and "you" correctly Loses skills he/she once had From 4 to < 5.5 year-old: Is easily distracted, has trouble focusing on one activity for more than 5 minutes • Doesn't talk about daily activities or experiences Shows extreme behavior Loses skills he/she once had

  7. Duration of breast-feeding [Up to 24 months after birth]

    Duration of breast-feeding

  8. Infant age at which weaning starts [Up to 24 months after birth]

    Infant age at which weaning starts

  9. Name of diseases that lead to hospital admission [Up to 66 months after birth]

    Name of diseases that lead to hospital admission

  10. Number of hospital admission [Up to 66 months after birth]

    Number of hospital admission

  11. Weight [Through study completion, an average of 1.5 months]

    Weight on the examination date

  12. Height [Through study completion, an average of 1.5 months]

    Height on the examination date

Other Outcome Measures

  1. The rate of long-term illness and chronic conditions [Up to 66 months after birth]

    Any long-term illness and chronic condition appears in a child

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 66 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Live babies born from The pessary versus vaginal progesterone in women with a twin pregnancy and a cervix <38 mm study (NCT02623881)

  • Parents agree to participate in the study.

Exclusion Criteria:
  • Babies died after the perinatal period.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mỹ Đức Hospital Ho Chi Minh City Vietnam

Sponsors and Collaborators

  • Mỹ Đức Hospital

Investigators

  • Principal Investigator: Dang Q Vinh, MD, Mỹ Đức Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mỹ Đức Hospital
ClinicalTrials.gov Identifier:
NCT04295187
Other Study ID Numbers:
  • CS/BVMĐ/20/03
First Posted:
Mar 4, 2020
Last Update Posted:
Feb 24, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mỹ Đức Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 24, 2021